|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:ARNT-CBLB (FusionGDB2 ID:HG405TG868) |
Fusion Gene Summary for ARNT-CBLB |
Fusion gene summary |
Fusion gene information | Fusion gene name: ARNT-CBLB | Fusion gene ID: hg405tg868 | Hgene | Tgene | Gene symbol | ARNT | CBLB | Gene ID | 405 | 868 |
Gene name | aryl hydrocarbon receptor nuclear translocator | Cbl proto-oncogene B | |
Synonyms | HIF-1-beta|HIF-1beta|HIF1-beta|HIF1B|HIF1BETA|TANGO|bHLHe2 | Cbl-b|Nbla00127|RNF56 | |
Cytomap | ('ARNT')('CBLB') 1q21.3 | 3q13.11 | |
Type of gene | protein-coding | protein-coding | |
Description | aryl hydrocarbon receptor nuclear translocatorclass E basic helix-loop-helix protein 2dioxin receptor, nuclear translocatorhypoxia-inducible factor 1, beta subunit | E3 ubiquitin-protein ligase CBL-BCas-Br-M (murine) ecotropic retroviral transforming sequence bCbl proto-oncogene B, E3 ubiquitin protein ligaseCbl proto-oncogene, E3 ubiquitin protein ligase BRING finger protein 56RING-type E3 ubiquitin transferase | |
Modification date | 20200315 | 20200327 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000354396, ENST00000358595, ENST00000505755, ENST00000515192, ENST00000468970, | ||
Fusion gene scores | * DoF score | 18 X 16 X 9=2592 | 13 X 14 X 7=1274 |
# samples | 18 | 16 | |
** MAII score | log2(18/2592*10)=-3.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(16/1274*10)=-2.99322146736894 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ARNT [Title/Abstract] AND CBLB [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ARNT(150849019)-CBLB(105439094), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | ARNT-CBLB seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ARNT-CBLB seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ARNT-CBLB seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ARNT-CBLB seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ARNT | GO:0001666 | response to hypoxia | 8756616 |
Hgene | ARNT | GO:0010575 | positive regulation of vascular endothelial growth factor production | 8756616 |
Hgene | ARNT | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress | 8089148 |
Hgene | ARNT | GO:0045893 | positive regulation of transcription, DNA-templated | 8089148 |
Hgene | ARNT | GO:0046886 | positive regulation of hormone biosynthetic process | 1448077 |
Fusion gene breakpoints across ARNT (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across CBLB (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LUAD | TCGA-O1-A52J-01A | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
Top |
Fusion Gene ORF analysis for ARNT-CBLB |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-3UTR | ENST00000354396 | ENST00000545639 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
5CDS-3UTR | ENST00000358595 | ENST00000545639 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
5CDS-3UTR | ENST00000505755 | ENST00000545639 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
5CDS-intron | ENST00000354396 | ENST00000394027 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
5CDS-intron | ENST00000354396 | ENST00000403724 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
5CDS-intron | ENST00000354396 | ENST00000405772 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
5CDS-intron | ENST00000354396 | ENST00000407712 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
5CDS-intron | ENST00000358595 | ENST00000394027 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
5CDS-intron | ENST00000358595 | ENST00000403724 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
5CDS-intron | ENST00000358595 | ENST00000405772 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
5CDS-intron | ENST00000358595 | ENST00000407712 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
5CDS-intron | ENST00000505755 | ENST00000394027 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
5CDS-intron | ENST00000505755 | ENST00000403724 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
5CDS-intron | ENST00000505755 | ENST00000405772 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
5CDS-intron | ENST00000505755 | ENST00000407712 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
5UTR-3CDS | ENST00000515192 | ENST00000264122 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
5UTR-3UTR | ENST00000515192 | ENST00000545639 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
5UTR-intron | ENST00000515192 | ENST00000394027 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
5UTR-intron | ENST00000515192 | ENST00000403724 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
5UTR-intron | ENST00000515192 | ENST00000405772 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
5UTR-intron | ENST00000515192 | ENST00000407712 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
In-frame | ENST00000354396 | ENST00000264122 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
In-frame | ENST00000358595 | ENST00000264122 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
In-frame | ENST00000505755 | ENST00000264122 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
intron-3CDS | ENST00000468970 | ENST00000264122 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
intron-3UTR | ENST00000468970 | ENST00000545639 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
intron-intron | ENST00000468970 | ENST00000394027 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
intron-intron | ENST00000468970 | ENST00000403724 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
intron-intron | ENST00000468970 | ENST00000405772 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
intron-intron | ENST00000468970 | ENST00000407712 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000358595 | ARNT | chr1 | 150849019 | - | ENST00000264122 | CBLB | chr3 | 105439094 | - | 5481 | 226 | 34 | 1971 | 645 |
ENST00000354396 | ARNT | chr1 | 150849019 | - | ENST00000264122 | CBLB | chr3 | 105439094 | - | 5292 | 37 | 4 | 1782 | 592 |
ENST00000505755 | ARNT | chr1 | 150849019 | - | ENST00000264122 | CBLB | chr3 | 105439094 | - | 5322 | 67 | 1 | 1812 | 603 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000358595 | ENST00000264122 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - | 0.001083971 | 0.99891603 |
ENST00000354396 | ENST00000264122 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - | 0.00104341 | 0.99895656 |
ENST00000505755 | ENST00000264122 | ARNT | chr1 | 150849019 | - | CBLB | chr3 | 105439094 | - | 0.001034657 | 0.9989654 |
Top |
Fusion Genomic Features for ARNT-CBLB |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Top |
Fusion Protein Features for ARNT-CBLB |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:150849019/chr3:105439094) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000264122 | 8 | 19 | 477_925 | 401 | 983.0 | Compositional bias | Note=Pro-rich | |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000403724 | 8 | 15 | 477_925 | 401 | 771.0 | Compositional bias | Note=Pro-rich | |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000264122 | 8 | 19 | 931_970 | 401 | 983.0 | Domain | UBA | |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000403724 | 8 | 15 | 931_970 | 401 | 771.0 | Domain | UBA |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000358595 | - | 1 | 22 | 503_507 | 8 | 790.0 | Compositional bias | Note=Poly-Gln |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000358595 | - | 1 | 22 | 710_769 | 8 | 790.0 | Compositional bias | Note=Gln-rich |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000358595 | - | 1 | 22 | 738_741 | 8 | 790.0 | Compositional bias | Note=Poly-Ser |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000358595 | - | 1 | 22 | 99_102 | 8 | 790.0 | Compositional bias | Note=Poly-Arg |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000505755 | - | 1 | 21 | 503_507 | 8 | 775.0 | Compositional bias | Note=Poly-Gln |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000505755 | - | 1 | 21 | 710_769 | 8 | 775.0 | Compositional bias | Note=Gln-rich |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000505755 | - | 1 | 21 | 738_741 | 8 | 775.0 | Compositional bias | Note=Poly-Ser |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000505755 | - | 1 | 21 | 99_102 | 8 | 775.0 | Compositional bias | Note=Poly-Arg |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000515192 | - | 1 | 23 | 503_507 | 0 | 776.0 | Compositional bias | Note=Poly-Gln |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000515192 | - | 1 | 23 | 710_769 | 0 | 776.0 | Compositional bias | Note=Gln-rich |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000515192 | - | 1 | 23 | 738_741 | 0 | 776.0 | Compositional bias | Note=Poly-Ser |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000515192 | - | 1 | 23 | 99_102 | 0 | 776.0 | Compositional bias | Note=Poly-Arg |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000358595 | - | 1 | 22 | 161_235 | 8 | 790.0 | Domain | PAS 1 |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000358595 | - | 1 | 22 | 349_419 | 8 | 790.0 | Domain | PAS 2 |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000358595 | - | 1 | 22 | 424_467 | 8 | 790.0 | Domain | Note=PAC |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000358595 | - | 1 | 22 | 89_142 | 8 | 790.0 | Domain | bHLH |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000505755 | - | 1 | 21 | 161_235 | 8 | 775.0 | Domain | PAS 1 |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000505755 | - | 1 | 21 | 349_419 | 8 | 775.0 | Domain | PAS 2 |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000505755 | - | 1 | 21 | 424_467 | 8 | 775.0 | Domain | Note=PAC |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000505755 | - | 1 | 21 | 89_142 | 8 | 775.0 | Domain | bHLH |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000515192 | - | 1 | 23 | 161_235 | 0 | 776.0 | Domain | PAS 1 |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000515192 | - | 1 | 23 | 349_419 | 0 | 776.0 | Domain | PAS 2 |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000515192 | - | 1 | 23 | 424_467 | 0 | 776.0 | Domain | Note=PAC |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000515192 | - | 1 | 23 | 89_142 | 0 | 776.0 | Domain | bHLH |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000358595 | - | 1 | 22 | 112_168 | 8 | 790.0 | Region | Required for heterodimer formation with HIF1A |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000358595 | - | 1 | 22 | 112_264 | 8 | 790.0 | Region | Required for heterodimer formation with EPAS1 |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000358595 | - | 1 | 22 | 167_171 | 8 | 790.0 | Region | Mediates the transcription activity and dimerization of the AHR:ARNT complex |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000358595 | - | 1 | 22 | 88_128 | 8 | 790.0 | Region | DNA-binding |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000505755 | - | 1 | 21 | 112_168 | 8 | 775.0 | Region | Required for heterodimer formation with HIF1A |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000505755 | - | 1 | 21 | 112_264 | 8 | 775.0 | Region | Required for heterodimer formation with EPAS1 |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000505755 | - | 1 | 21 | 167_171 | 8 | 775.0 | Region | Mediates the transcription activity and dimerization of the AHR:ARNT complex |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000505755 | - | 1 | 21 | 88_128 | 8 | 775.0 | Region | DNA-binding |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000515192 | - | 1 | 23 | 112_168 | 0 | 776.0 | Region | Required for heterodimer formation with HIF1A |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000515192 | - | 1 | 23 | 112_264 | 0 | 776.0 | Region | Required for heterodimer formation with EPAS1 |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000515192 | - | 1 | 23 | 167_171 | 0 | 776.0 | Region | Mediates the transcription activity and dimerization of the AHR:ARNT complex |
Hgene | ARNT | chr1:150849019 | chr3:105439094 | ENST00000515192 | - | 1 | 23 | 88_128 | 0 | 776.0 | Region | DNA-binding |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000264122 | 8 | 19 | 219_232 | 401 | 983.0 | Calcium binding | Ontology_term=ECO:0000255 | |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000403724 | 8 | 15 | 219_232 | 401 | 771.0 | Calcium binding | Ontology_term=ECO:0000255 | |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000264122 | 8 | 19 | 35_343 | 401 | 983.0 | Domain | Cbl-PTB | |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000403724 | 8 | 15 | 35_343 | 401 | 771.0 | Domain | Cbl-PTB | |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000264122 | 8 | 19 | 168_240 | 401 | 983.0 | Region | Note=EF-hand-like | |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000264122 | 8 | 19 | 241_343 | 401 | 983.0 | Region | Note=SH2-like | |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000264122 | 8 | 19 | 344_372 | 401 | 983.0 | Region | Note=Linker | |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000264122 | 8 | 19 | 35_167 | 401 | 983.0 | Region | Note=4H | |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000403724 | 8 | 15 | 168_240 | 401 | 771.0 | Region | Note=EF-hand-like | |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000403724 | 8 | 15 | 241_343 | 401 | 771.0 | Region | Note=SH2-like | |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000403724 | 8 | 15 | 344_372 | 401 | 771.0 | Region | Note=Linker | |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000403724 | 8 | 15 | 35_167 | 401 | 771.0 | Region | Note=4H | |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000264122 | 8 | 19 | 373_412 | 401 | 983.0 | Zinc finger | RING-type | |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000403724 | 8 | 15 | 373_412 | 401 | 771.0 | Zinc finger | RING-type |
Top |
Fusion Gene Sequence for ARNT-CBLB |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>6734_6734_1_ARNT-CBLB_ARNT_chr1_150849019_ENST00000354396_CBLB_chr3_105439094_ENST00000264122_length(transcript)=5292nt_BP=37nt GCATCTGCGGCCATGGCGGCGACTACTGCCAACCCCGGAGTCGGATGGTCAGGGCTGCCCTTTCTGTCGTTGTGAAATAAAAGGAACTGA GCCCATAATCGTGGACCCCTTTGATCCAAGAGATGAAGGCTCCAGGTGTTGCAGCATCATTGACCCCTTTGGCATGCCGATGCTAGACTT GGACGACGATGATGATCGTGAGGAGTCCTTGATGATGAATCGGTTGGCAAACGTCCGAAAGTGCACTGACAGGCAGAACTCACCAGTCAC ATCACCAGGATCCTCTCCCCTTGCCCAGAGAAGAAAGCCACAGCCTGACCCACTCCAGATCCCACATCTAAGCCTGCCACCCGTGCCTCC TCGCCTGGATCTAATTCAGAAAGGCATAGTTAGATCTCCCTGTGGCAGCCCAACGGGTTCACCAAAGTCTTCTCCTTGCATGGTGAGAAA ACAAGATAAACCACTCCCAGCACCACCTCCTCCCTTAAGAGATCCTCCTCCACCGCCACCTGAAAGACCTCCACCAATCCCACCAGACAA TAGACTGAGTAGACACATCCATCATGTGGAAAGCGTGCCTTCCAGAGACCCGCCAATGCCTCTTGAAGCATGGTGCCCTCGGGATGTGTT TGGGACTAATCAGCTTGTGGGATGTCGACTCCTAGGGGAGGGCTCTCCAAAACCTGGAATCACAGCGAGTTCAAATGTCAATGGAAGGCA CAGTAGAGTGGGCTCTGACCCAGTGCTTATGCGGAAACACAGACGCCATGATTTGCCTTTAGAAGGAGCTAAGGTCTTTTCCAATGGTCA CCTTGGAAGTGAAGAATATGATGTTCCTCCCCGGCTTTCTCCTCCTCCTCCAGTTACCACCCTCCTCCCTAGCATAAAGTGTACTGGTCC GTTAGCAAATTCTCTTTCAGAGAAAACAAGAGACCCAGTAGAGGAAGATGATGATGAATACAAGATTCCTTCATCCCACCCTGTTTCCCT GAATTCACAACCATCTCATTGTCATAATGTAAAACCTCCTGTTCGGTCTTGTGATAATGGTCACTGTATGCTGAATGGAACACATGGTCC ATCTTCAGAGAAGAAATCAAACATCCCTGACTTAAGCATATATTTAAAGGGAGATGTTTTTGATTCAGCCTCTGATCCCGTGCCATTACC ACCTGCCAGGCCTCCAACTCGGGACAATCCAAAGCATGGTTCTTCACTCAACAGGACGCCCTCTGATTATGATCTTCTCATCCCTCCATT AGGTGAAGATGCTTTTGATGCCCTCCCTCCATCTCTCCCACCTCCCCCACCTCCTGCAAGGCATAGTCTCATTGAACATTCAAAACCTCC TGGCTCCAGTAGCCGGCCATCCTCAGGACAGGATCTTTTTCTTCTTCCTTCAGATCCCTTTGTTGATCTAGCAAGTGGCCAAGTTCCTTT GCCTCCTGCTAGAAGGTTACCAGGTGAAAATGTCAAAACTAACAGAACATCACAGGACTATGATCAGCTTCCTTCATGTTCAGATGGTTC ACAGGCACCAGCCAGACCCCCTAAACCACGACCGCGCAGGACTGCACCAGAAATTCACCACAGAAAACCCCATGGGCCTGAGGCGGCATT GGAAAATGTCGATGCAAAAATTGCAAAACTCATGGGAGAGGGTTATGCCTTTGAAGAGGTGAAGAGAGCCTTAGAGATAGCCCAGAATAA TGTCGAAGTTGCCCGGAGCATCCTCCGAGAATTTGCCTTCCCTCCTCCAGTATCCCCACGTCTAAATCTATAGCAGCCAGAACTGTAGAC ACCAAAATGGAAAGCAATCGATGTATTCCAAGAGTGTGGAAATAAAGAGAACTGAGATGGAATTCAAGAGAGAAGTGTCTCCTCCTCGTG TAGCAGCTTGAGAAGAGGCTTGGGAGTGCAGCTTCTCAAAGGAGACCGATGCTTGCTCAGGATGTCGACAGCTGTGGCTTCCTTGTTTTT GCTAGCCATATTTTTAAATCAGGGTTGAACTGACAAAAATAATTTAAAGACGTTTACTTCCCTTGAACTTTGAACCTGTGAAATGCTTTA CCTTGTTTACAGTTTGGCAAAGTTGCAGTTTGTTCTTGTTTTTAGTTTAGTTTTGTTTTGGTGTTTTGATACCTGTACTGTGTTCTTCAC AGACCCTTTGTAGCGTGGTCAGGTCTGCTGTAACATTTCCCACCAACTCTCTTGCTGTCCACATCAACAGCTAAATCATTTATTCATATG GATCTCTACCATCCCCATGCCTTGCCCAGGTCCAGTTCCATTTCTCTCATTCACAAGATGCTTTGAAGGTTCTGATTTTCAACTGATCAA ACTAATGCAAAAAAAAAAAAGTATGTATTCTTCACTACTGAGTTTCTTCTTTGGAAACCATCACTATTGAGAGATGGGAAAAACCTGAAT GTATAAAGCATTTATTTGTCAATAAACTGCCTTTTGTAAGGGGTTTTCACATAACATAGAGGAGCTTCCCTTTTTTGTTTAAGTTTTGTA ACCTTTAATCCTCCATATTCTCATGTCTGTCATCCCAGGGGTGTCACAACTGTAAAAATCTACAATATTAGAAAGCAGCTACTACAGATG TGGAAGAGAGAACACTTGTATAAGACAATGCTGTACTGAAGTTATATAACAAGGTCCCCTGATACTTATGCCTGCATTACTTTGAGGGAT GCTGAATGAGAGGACCATCTCCCTGAAATATATTAATAATTTTCAGATAAAATTATGAACATAACATACCTTTTCTCAAGTGGAATTAGA GTTCATTTCCCATTTAAGTGATTACACTCTATCTCCTAAGAGCTGTGGGAACCAGTTCATATTGCAGTGGAAACATTAACTCTTCGTTGC ACTGTTGAGTGTCAAGGCTACTGTGGCAATGTTTTTTGCAAAGTTCTCAGTAATTTTCTCTCTGCAATCAAATTAGAGTTCATATTTAAT TTGCAGATTCTCTCATTCATTGCTCCACACTGCTTTATCAAATCAGGTGAAAGAAATTAATGTAGTTTTGCCTATTTTACAAAATGGTGG TTGGTTCTTTAAACACCATGTTATTACTCTTAATAAATCTACAAATATTTATTGAGCATCTATGATATGCTTGGTGCTGTTAGGCACTGT GTTTTTAAAGCACAAACTCTCAAAAGCTGATTCCAGCGTAATGTTTTATTTTTGTTTTTCTGTGTTTTTTATGACAAAGTCTGTCTGATA GACAAAGCCTGGAAGGTTTCCCCCAGGGCTTTAGAATTTAGAATTAGCTGGTTTTCATTTCAAATGGGAAATTAATGGAGAAATGAGATA AAATCATCTCTGTGTAAATGCTTGAACCCACAGAAAGTTTTCTAAATATGGACTAATTGTGGGTTTGTGCATATTTCTGTGTCTCCTCTT TTCACTTCACACCCACCATGATATAAAAAGATGCATCAGAGAGTGAGCCTGCCTTCAGGACCTGAAAGGACATGACTGAACATCTAGTAG ATCTGGTGGAAATTAATGTTATACAAAAGACACGTAGACTAAGTTGACCCTGGGAGAGGAGTTAATACATTCCTTTGCAAAGTGACATGT GCCCTTTTTTTGACAGTCTGGCTTTCATGGTATGAGATGAGGACTCACAGGCCTTGGGTAATTTCTGCTTTTGTATGAATTTTTTCAGAT GGTTCTGAGCTGGTTATGTCCCTGGAGGGGAATTTTTCATTTGCCTTAGATGTTCTTCCCATGAGTAGGTACATGAGTGAAGTTTCTTAC ACTTTTAAAATTGCATTGGCAAATTTTCTTTTGCTTTATGAACCCCTGTTTTGTCATTATGATTTTTCACTTGTTTTAACAGTTTCAGAT GTCACCTTGGAATAGCACTGTTTATTTTGGCCTTTTTATGATTGCTGATGATAGGTACAGTCTAAAGGCCAAAAGTTGCCACTTCATTGT GATAACATTGTTGCAACATTCCTAATATATTAGAGAATGATGTAAAATAAGAATGTTAGAGAACATAGCACATTCTCATTCAGTTTATAA ACAATATTTGAAAATTTCCAGTGAGAATTAAAAAAGGACTAGTGATGATATAGCAAACCTGGACCTGAAATTTGGGGGTGGGGGGTGGGG GGATATCTGTTTTGCAGAGAAAATTTACCAGCCTCCAGCAAAATCTCTGCATCTTGTACTCAATAGCAACCATTAGTATTGTCATTTAAA AAGAATGAATCAAAAATTCATACGTAATGGAATGAAAAGAGGAAAACTTTCTATTAAACACTGTCAAGAAAGACCCATTGCTATCTATCA CCTATGAAATTAAACCTAAAAAAATTTTTTTTTATTGTAAAAGCGACTGCTCGTTGATGTCTGGAAGTGATCCAGACTTTGTTTCACTGT GATCCAAAAAGTTAGACATTCCTTCCATTTCTCAAGATTTGGTAACAATTTTTTTTTAAGTCAGCATTTCATATAATACATAAAATTAAG ACAAATTAACTTACTGATATGTGGCCAATATCAACCCTTCTCACCCAACCCAAACATGTTCTGGAGATAGAAGGACTTATCCTCAATTAT ATTCCAGTAAATTTATCTCCATAATCTGTTTTATCCCCTAATGTATGATATATCTCACCAAATTTTTCTAGAATTGAATAAAAGCAGTTT TTGCTTAACTTGAATTTCCTTCCACAAATACAACCTTCAGCTCTTCCCTCTCTGTTTCCCTTTTGCCCACATTGCAAATAGTCTTCATAA TAGAACCCTCACTGCAACTTAAAAGGGTCCCATTTCTTAACTCAGCATTTCATATACCAAGAACACTTGCAAAGATTTCTTCATAATGTG ATTTTTTAATTTTTCAGTTCCAGAAGCATTTCCTACAGTTCGAACGTTATTTTTTCTCTCAGATTTTCAACTTGAAGCTTTGATTTGCAC TGAATTAACTTGGATAAAATTTTAGTTTCTCTCTTCAGCTAACAGATTTGGAAGCAAATTACAGTATACTTGAATAATTCAGGTACTACC TGTTGACCTGGAATTTTAGTGATTCTGGGAAAGTTTTCCAGACAAAGACACCAATAGAGTGAAGGGTTTTTTCCCCAATTACTATTTTAT TGTTTTTTAAAATGCCTTTTTAAAACTTGTGTGATGTGGCAAAATAGTCATATGTTCAATTAATTTATATTTTATTCATTCCTTTTCAAT >6734_6734_1_ARNT-CBLB_ARNT_chr1_150849019_ENST00000354396_CBLB_chr3_105439094_ENST00000264122_length(amino acids)=592AA_BP=11 MRPWRRLLPTPESDGQGCPFCRCEIKGTEPIIVDPFDPRDEGSRCCSIIDPFGMPMLDLDDDDDREESLMMNRLANVRKCTDRQNSPVTS PGSSPLAQRRKPQPDPLQIPHLSLPPVPPRLDLIQKGIVRSPCGSPTGSPKSSPCMVRKQDKPLPAPPPPLRDPPPPPPERPPPIPPDNR LSRHIHHVESVPSRDPPMPLEAWCPRDVFGTNQLVGCRLLGEGSPKPGITASSNVNGRHSRVGSDPVLMRKHRRHDLPLEGAKVFSNGHL GSEEYDVPPRLSPPPPVTTLLPSIKCTGPLANSLSEKTRDPVEEDDDEYKIPSSHPVSLNSQPSHCHNVKPPVRSCDNGHCMLNGTHGPS SEKKSNIPDLSIYLKGDVFDSASDPVPLPPARPPTRDNPKHGSSLNRTPSDYDLLIPPLGEDAFDALPPSLPPPPPPARHSLIEHSKPPG SSSRPSSGQDLFLLPSDPFVDLASGQVPLPPARRLPGENVKTNRTSQDYDQLPSCSDGSQAPARPPKPRPRRTAPEIHHRKPHGPEAALE -------------------------------------------------------------- >6734_6734_2_ARNT-CBLB_ARNT_chr1_150849019_ENST00000358595_CBLB_chr3_105439094_ENST00000264122_length(transcript)=5481nt_BP=226nt ATATAGGCGGGGTCTCCCCGCCGCAGGGGCTGGGATGCTGGGGGCTGCTGAAGCCGCCATCTTGGATTCCGCGGTAGCGGAGGCGGCGGT CAGGCGCCGCTTCTGGGGAGTGGCCTTTCTTTTCCCCTCCCTCCCGGTTCGGTGGCGGCGGCTCCTCCCACTGGGGGGGGGGGTGGCGCG GCGGCGGTGGCATCTGCGGCCATGGCGGCGACTACTGCCAACCCCGGAGTCGGATGGTCAGGGCTGCCCTTTCTGTCGTTGTGAAATAAA AGGAACTGAGCCCATAATCGTGGACCCCTTTGATCCAAGAGATGAAGGCTCCAGGTGTTGCAGCATCATTGACCCCTTTGGCATGCCGAT GCTAGACTTGGACGACGATGATGATCGTGAGGAGTCCTTGATGATGAATCGGTTGGCAAACGTCCGAAAGTGCACTGACAGGCAGAACTC ACCAGTCACATCACCAGGATCCTCTCCCCTTGCCCAGAGAAGAAAGCCACAGCCTGACCCACTCCAGATCCCACATCTAAGCCTGCCACC CGTGCCTCCTCGCCTGGATCTAATTCAGAAAGGCATAGTTAGATCTCCCTGTGGCAGCCCAACGGGTTCACCAAAGTCTTCTCCTTGCAT GGTGAGAAAACAAGATAAACCACTCCCAGCACCACCTCCTCCCTTAAGAGATCCTCCTCCACCGCCACCTGAAAGACCTCCACCAATCCC ACCAGACAATAGACTGAGTAGACACATCCATCATGTGGAAAGCGTGCCTTCCAGAGACCCGCCAATGCCTCTTGAAGCATGGTGCCCTCG GGATGTGTTTGGGACTAATCAGCTTGTGGGATGTCGACTCCTAGGGGAGGGCTCTCCAAAACCTGGAATCACAGCGAGTTCAAATGTCAA TGGAAGGCACAGTAGAGTGGGCTCTGACCCAGTGCTTATGCGGAAACACAGACGCCATGATTTGCCTTTAGAAGGAGCTAAGGTCTTTTC CAATGGTCACCTTGGAAGTGAAGAATATGATGTTCCTCCCCGGCTTTCTCCTCCTCCTCCAGTTACCACCCTCCTCCCTAGCATAAAGTG TACTGGTCCGTTAGCAAATTCTCTTTCAGAGAAAACAAGAGACCCAGTAGAGGAAGATGATGATGAATACAAGATTCCTTCATCCCACCC TGTTTCCCTGAATTCACAACCATCTCATTGTCATAATGTAAAACCTCCTGTTCGGTCTTGTGATAATGGTCACTGTATGCTGAATGGAAC ACATGGTCCATCTTCAGAGAAGAAATCAAACATCCCTGACTTAAGCATATATTTAAAGGGAGATGTTTTTGATTCAGCCTCTGATCCCGT GCCATTACCACCTGCCAGGCCTCCAACTCGGGACAATCCAAAGCATGGTTCTTCACTCAACAGGACGCCCTCTGATTATGATCTTCTCAT CCCTCCATTAGGTGAAGATGCTTTTGATGCCCTCCCTCCATCTCTCCCACCTCCCCCACCTCCTGCAAGGCATAGTCTCATTGAACATTC AAAACCTCCTGGCTCCAGTAGCCGGCCATCCTCAGGACAGGATCTTTTTCTTCTTCCTTCAGATCCCTTTGTTGATCTAGCAAGTGGCCA AGTTCCTTTGCCTCCTGCTAGAAGGTTACCAGGTGAAAATGTCAAAACTAACAGAACATCACAGGACTATGATCAGCTTCCTTCATGTTC AGATGGTTCACAGGCACCAGCCAGACCCCCTAAACCACGACCGCGCAGGACTGCACCAGAAATTCACCACAGAAAACCCCATGGGCCTGA GGCGGCATTGGAAAATGTCGATGCAAAAATTGCAAAACTCATGGGAGAGGGTTATGCCTTTGAAGAGGTGAAGAGAGCCTTAGAGATAGC CCAGAATAATGTCGAAGTTGCCCGGAGCATCCTCCGAGAATTTGCCTTCCCTCCTCCAGTATCCCCACGTCTAAATCTATAGCAGCCAGA ACTGTAGACACCAAAATGGAAAGCAATCGATGTATTCCAAGAGTGTGGAAATAAAGAGAACTGAGATGGAATTCAAGAGAGAAGTGTCTC CTCCTCGTGTAGCAGCTTGAGAAGAGGCTTGGGAGTGCAGCTTCTCAAAGGAGACCGATGCTTGCTCAGGATGTCGACAGCTGTGGCTTC CTTGTTTTTGCTAGCCATATTTTTAAATCAGGGTTGAACTGACAAAAATAATTTAAAGACGTTTACTTCCCTTGAACTTTGAACCTGTGA AATGCTTTACCTTGTTTACAGTTTGGCAAAGTTGCAGTTTGTTCTTGTTTTTAGTTTAGTTTTGTTTTGGTGTTTTGATACCTGTACTGT GTTCTTCACAGACCCTTTGTAGCGTGGTCAGGTCTGCTGTAACATTTCCCACCAACTCTCTTGCTGTCCACATCAACAGCTAAATCATTT ATTCATATGGATCTCTACCATCCCCATGCCTTGCCCAGGTCCAGTTCCATTTCTCTCATTCACAAGATGCTTTGAAGGTTCTGATTTTCA ACTGATCAAACTAATGCAAAAAAAAAAAAGTATGTATTCTTCACTACTGAGTTTCTTCTTTGGAAACCATCACTATTGAGAGATGGGAAA AACCTGAATGTATAAAGCATTTATTTGTCAATAAACTGCCTTTTGTAAGGGGTTTTCACATAACATAGAGGAGCTTCCCTTTTTTGTTTA AGTTTTGTAACCTTTAATCCTCCATATTCTCATGTCTGTCATCCCAGGGGTGTCACAACTGTAAAAATCTACAATATTAGAAAGCAGCTA CTACAGATGTGGAAGAGAGAACACTTGTATAAGACAATGCTGTACTGAAGTTATATAACAAGGTCCCCTGATACTTATGCCTGCATTACT TTGAGGGATGCTGAATGAGAGGACCATCTCCCTGAAATATATTAATAATTTTCAGATAAAATTATGAACATAACATACCTTTTCTCAAGT GGAATTAGAGTTCATTTCCCATTTAAGTGATTACACTCTATCTCCTAAGAGCTGTGGGAACCAGTTCATATTGCAGTGGAAACATTAACT CTTCGTTGCACTGTTGAGTGTCAAGGCTACTGTGGCAATGTTTTTTGCAAAGTTCTCAGTAATTTTCTCTCTGCAATCAAATTAGAGTTC ATATTTAATTTGCAGATTCTCTCATTCATTGCTCCACACTGCTTTATCAAATCAGGTGAAAGAAATTAATGTAGTTTTGCCTATTTTACA AAATGGTGGTTGGTTCTTTAAACACCATGTTATTACTCTTAATAAATCTACAAATATTTATTGAGCATCTATGATATGCTTGGTGCTGTT AGGCACTGTGTTTTTAAAGCACAAACTCTCAAAAGCTGATTCCAGCGTAATGTTTTATTTTTGTTTTTCTGTGTTTTTTATGACAAAGTC TGTCTGATAGACAAAGCCTGGAAGGTTTCCCCCAGGGCTTTAGAATTTAGAATTAGCTGGTTTTCATTTCAAATGGGAAATTAATGGAGA AATGAGATAAAATCATCTCTGTGTAAATGCTTGAACCCACAGAAAGTTTTCTAAATATGGACTAATTGTGGGTTTGTGCATATTTCTGTG TCTCCTCTTTTCACTTCACACCCACCATGATATAAAAAGATGCATCAGAGAGTGAGCCTGCCTTCAGGACCTGAAAGGACATGACTGAAC ATCTAGTAGATCTGGTGGAAATTAATGTTATACAAAAGACACGTAGACTAAGTTGACCCTGGGAGAGGAGTTAATACATTCCTTTGCAAA GTGACATGTGCCCTTTTTTTGACAGTCTGGCTTTCATGGTATGAGATGAGGACTCACAGGCCTTGGGTAATTTCTGCTTTTGTATGAATT TTTTCAGATGGTTCTGAGCTGGTTATGTCCCTGGAGGGGAATTTTTCATTTGCCTTAGATGTTCTTCCCATGAGTAGGTACATGAGTGAA GTTTCTTACACTTTTAAAATTGCATTGGCAAATTTTCTTTTGCTTTATGAACCCCTGTTTTGTCATTATGATTTTTCACTTGTTTTAACA GTTTCAGATGTCACCTTGGAATAGCACTGTTTATTTTGGCCTTTTTATGATTGCTGATGATAGGTACAGTCTAAAGGCCAAAAGTTGCCA CTTCATTGTGATAACATTGTTGCAACATTCCTAATATATTAGAGAATGATGTAAAATAAGAATGTTAGAGAACATAGCACATTCTCATTC AGTTTATAAACAATATTTGAAAATTTCCAGTGAGAATTAAAAAAGGACTAGTGATGATATAGCAAACCTGGACCTGAAATTTGGGGGTGG GGGGTGGGGGGATATCTGTTTTGCAGAGAAAATTTACCAGCCTCCAGCAAAATCTCTGCATCTTGTACTCAATAGCAACCATTAGTATTG TCATTTAAAAAGAATGAATCAAAAATTCATACGTAATGGAATGAAAAGAGGAAAACTTTCTATTAAACACTGTCAAGAAAGACCCATTGC TATCTATCACCTATGAAATTAAACCTAAAAAAATTTTTTTTTATTGTAAAAGCGACTGCTCGTTGATGTCTGGAAGTGATCCAGACTTTG TTTCACTGTGATCCAAAAAGTTAGACATTCCTTCCATTTCTCAAGATTTGGTAACAATTTTTTTTTAAGTCAGCATTTCATATAATACAT AAAATTAAGACAAATTAACTTACTGATATGTGGCCAATATCAACCCTTCTCACCCAACCCAAACATGTTCTGGAGATAGAAGGACTTATC CTCAATTATATTCCAGTAAATTTATCTCCATAATCTGTTTTATCCCCTAATGTATGATATATCTCACCAAATTTTTCTAGAATTGAATAA AAGCAGTTTTTGCTTAACTTGAATTTCCTTCCACAAATACAACCTTCAGCTCTTCCCTCTCTGTTTCCCTTTTGCCCACATTGCAAATAG TCTTCATAATAGAACCCTCACTGCAACTTAAAAGGGTCCCATTTCTTAACTCAGCATTTCATATACCAAGAACACTTGCAAAGATTTCTT CATAATGTGATTTTTTAATTTTTCAGTTCCAGAAGCATTTCCTACAGTTCGAACGTTATTTTTTCTCTCAGATTTTCAACTTGAAGCTTT GATTTGCACTGAATTAACTTGGATAAAATTTTAGTTTCTCTCTTCAGCTAACAGATTTGGAAGCAAATTACAGTATACTTGAATAATTCA GGTACTACCTGTTGACCTGGAATTTTAGTGATTCTGGGAAAGTTTTCCAGACAAAGACACCAATAGAGTGAAGGGTTTTTTCCCCAATTA CTATTTTATTGTTTTTTAAAATGCCTTTTTAAAACTTGTGTGATGTGGCAAAATAGTCATATGTTCAATTAATTTATATTTTATTCATTC >6734_6734_2_ARNT-CBLB_ARNT_chr1_150849019_ENST00000358595_CBLB_chr3_105439094_ENST00000264122_length(amino acids)=645AA_BP=64 MLGAAEAAILDSAVAEAAVRRRFWGVAFLFPSLPVRWRRLLPLGGGVARRRWHLRPWRRLLPTPESDGQGCPFCRCEIKGTEPIIVDPFD PRDEGSRCCSIIDPFGMPMLDLDDDDDREESLMMNRLANVRKCTDRQNSPVTSPGSSPLAQRRKPQPDPLQIPHLSLPPVPPRLDLIQKG IVRSPCGSPTGSPKSSPCMVRKQDKPLPAPPPPLRDPPPPPPERPPPIPPDNRLSRHIHHVESVPSRDPPMPLEAWCPRDVFGTNQLVGC RLLGEGSPKPGITASSNVNGRHSRVGSDPVLMRKHRRHDLPLEGAKVFSNGHLGSEEYDVPPRLSPPPPVTTLLPSIKCTGPLANSLSEK TRDPVEEDDDEYKIPSSHPVSLNSQPSHCHNVKPPVRSCDNGHCMLNGTHGPSSEKKSNIPDLSIYLKGDVFDSASDPVPLPPARPPTRD NPKHGSSLNRTPSDYDLLIPPLGEDAFDALPPSLPPPPPPARHSLIEHSKPPGSSSRPSSGQDLFLLPSDPFVDLASGQVPLPPARRLPG ENVKTNRTSQDYDQLPSCSDGSQAPARPPKPRPRRTAPEIHHRKPHGPEAALENVDAKIAKLMGEGYAFEEVKRALEIAQNNVEVARSIL -------------------------------------------------------------- >6734_6734_3_ARNT-CBLB_ARNT_chr1_150849019_ENST00000505755_CBLB_chr3_105439094_ENST00000264122_length(transcript)=5322nt_BP=67nt ACTGGGGGGGGGGGTGGCGCGGCGGCGGTGGCATCTGCGGCCATGGCGGCGACTACTGCCAACCCCGGAGTCGGATGGTCAGGGCTGCCC TTTCTGTCGTTGTGAAATAAAAGGAACTGAGCCCATAATCGTGGACCCCTTTGATCCAAGAGATGAAGGCTCCAGGTGTTGCAGCATCAT TGACCCCTTTGGCATGCCGATGCTAGACTTGGACGACGATGATGATCGTGAGGAGTCCTTGATGATGAATCGGTTGGCAAACGTCCGAAA GTGCACTGACAGGCAGAACTCACCAGTCACATCACCAGGATCCTCTCCCCTTGCCCAGAGAAGAAAGCCACAGCCTGACCCACTCCAGAT CCCACATCTAAGCCTGCCACCCGTGCCTCCTCGCCTGGATCTAATTCAGAAAGGCATAGTTAGATCTCCCTGTGGCAGCCCAACGGGTTC ACCAAAGTCTTCTCCTTGCATGGTGAGAAAACAAGATAAACCACTCCCAGCACCACCTCCTCCCTTAAGAGATCCTCCTCCACCGCCACC TGAAAGACCTCCACCAATCCCACCAGACAATAGACTGAGTAGACACATCCATCATGTGGAAAGCGTGCCTTCCAGAGACCCGCCAATGCC TCTTGAAGCATGGTGCCCTCGGGATGTGTTTGGGACTAATCAGCTTGTGGGATGTCGACTCCTAGGGGAGGGCTCTCCAAAACCTGGAAT CACAGCGAGTTCAAATGTCAATGGAAGGCACAGTAGAGTGGGCTCTGACCCAGTGCTTATGCGGAAACACAGACGCCATGATTTGCCTTT AGAAGGAGCTAAGGTCTTTTCCAATGGTCACCTTGGAAGTGAAGAATATGATGTTCCTCCCCGGCTTTCTCCTCCTCCTCCAGTTACCAC CCTCCTCCCTAGCATAAAGTGTACTGGTCCGTTAGCAAATTCTCTTTCAGAGAAAACAAGAGACCCAGTAGAGGAAGATGATGATGAATA CAAGATTCCTTCATCCCACCCTGTTTCCCTGAATTCACAACCATCTCATTGTCATAATGTAAAACCTCCTGTTCGGTCTTGTGATAATGG TCACTGTATGCTGAATGGAACACATGGTCCATCTTCAGAGAAGAAATCAAACATCCCTGACTTAAGCATATATTTAAAGGGAGATGTTTT TGATTCAGCCTCTGATCCCGTGCCATTACCACCTGCCAGGCCTCCAACTCGGGACAATCCAAAGCATGGTTCTTCACTCAACAGGACGCC CTCTGATTATGATCTTCTCATCCCTCCATTAGGTGAAGATGCTTTTGATGCCCTCCCTCCATCTCTCCCACCTCCCCCACCTCCTGCAAG GCATAGTCTCATTGAACATTCAAAACCTCCTGGCTCCAGTAGCCGGCCATCCTCAGGACAGGATCTTTTTCTTCTTCCTTCAGATCCCTT TGTTGATCTAGCAAGTGGCCAAGTTCCTTTGCCTCCTGCTAGAAGGTTACCAGGTGAAAATGTCAAAACTAACAGAACATCACAGGACTA TGATCAGCTTCCTTCATGTTCAGATGGTTCACAGGCACCAGCCAGACCCCCTAAACCACGACCGCGCAGGACTGCACCAGAAATTCACCA CAGAAAACCCCATGGGCCTGAGGCGGCATTGGAAAATGTCGATGCAAAAATTGCAAAACTCATGGGAGAGGGTTATGCCTTTGAAGAGGT GAAGAGAGCCTTAGAGATAGCCCAGAATAATGTCGAAGTTGCCCGGAGCATCCTCCGAGAATTTGCCTTCCCTCCTCCAGTATCCCCACG TCTAAATCTATAGCAGCCAGAACTGTAGACACCAAAATGGAAAGCAATCGATGTATTCCAAGAGTGTGGAAATAAAGAGAACTGAGATGG AATTCAAGAGAGAAGTGTCTCCTCCTCGTGTAGCAGCTTGAGAAGAGGCTTGGGAGTGCAGCTTCTCAAAGGAGACCGATGCTTGCTCAG GATGTCGACAGCTGTGGCTTCCTTGTTTTTGCTAGCCATATTTTTAAATCAGGGTTGAACTGACAAAAATAATTTAAAGACGTTTACTTC CCTTGAACTTTGAACCTGTGAAATGCTTTACCTTGTTTACAGTTTGGCAAAGTTGCAGTTTGTTCTTGTTTTTAGTTTAGTTTTGTTTTG GTGTTTTGATACCTGTACTGTGTTCTTCACAGACCCTTTGTAGCGTGGTCAGGTCTGCTGTAACATTTCCCACCAACTCTCTTGCTGTCC ACATCAACAGCTAAATCATTTATTCATATGGATCTCTACCATCCCCATGCCTTGCCCAGGTCCAGTTCCATTTCTCTCATTCACAAGATG CTTTGAAGGTTCTGATTTTCAACTGATCAAACTAATGCAAAAAAAAAAAAGTATGTATTCTTCACTACTGAGTTTCTTCTTTGGAAACCA TCACTATTGAGAGATGGGAAAAACCTGAATGTATAAAGCATTTATTTGTCAATAAACTGCCTTTTGTAAGGGGTTTTCACATAACATAGA GGAGCTTCCCTTTTTTGTTTAAGTTTTGTAACCTTTAATCCTCCATATTCTCATGTCTGTCATCCCAGGGGTGTCACAACTGTAAAAATC TACAATATTAGAAAGCAGCTACTACAGATGTGGAAGAGAGAACACTTGTATAAGACAATGCTGTACTGAAGTTATATAACAAGGTCCCCT GATACTTATGCCTGCATTACTTTGAGGGATGCTGAATGAGAGGACCATCTCCCTGAAATATATTAATAATTTTCAGATAAAATTATGAAC ATAACATACCTTTTCTCAAGTGGAATTAGAGTTCATTTCCCATTTAAGTGATTACACTCTATCTCCTAAGAGCTGTGGGAACCAGTTCAT ATTGCAGTGGAAACATTAACTCTTCGTTGCACTGTTGAGTGTCAAGGCTACTGTGGCAATGTTTTTTGCAAAGTTCTCAGTAATTTTCTC TCTGCAATCAAATTAGAGTTCATATTTAATTTGCAGATTCTCTCATTCATTGCTCCACACTGCTTTATCAAATCAGGTGAAAGAAATTAA TGTAGTTTTGCCTATTTTACAAAATGGTGGTTGGTTCTTTAAACACCATGTTATTACTCTTAATAAATCTACAAATATTTATTGAGCATC TATGATATGCTTGGTGCTGTTAGGCACTGTGTTTTTAAAGCACAAACTCTCAAAAGCTGATTCCAGCGTAATGTTTTATTTTTGTTTTTC TGTGTTTTTTATGACAAAGTCTGTCTGATAGACAAAGCCTGGAAGGTTTCCCCCAGGGCTTTAGAATTTAGAATTAGCTGGTTTTCATTT CAAATGGGAAATTAATGGAGAAATGAGATAAAATCATCTCTGTGTAAATGCTTGAACCCACAGAAAGTTTTCTAAATATGGACTAATTGT GGGTTTGTGCATATTTCTGTGTCTCCTCTTTTCACTTCACACCCACCATGATATAAAAAGATGCATCAGAGAGTGAGCCTGCCTTCAGGA CCTGAAAGGACATGACTGAACATCTAGTAGATCTGGTGGAAATTAATGTTATACAAAAGACACGTAGACTAAGTTGACCCTGGGAGAGGA GTTAATACATTCCTTTGCAAAGTGACATGTGCCCTTTTTTTGACAGTCTGGCTTTCATGGTATGAGATGAGGACTCACAGGCCTTGGGTA ATTTCTGCTTTTGTATGAATTTTTTCAGATGGTTCTGAGCTGGTTATGTCCCTGGAGGGGAATTTTTCATTTGCCTTAGATGTTCTTCCC ATGAGTAGGTACATGAGTGAAGTTTCTTACACTTTTAAAATTGCATTGGCAAATTTTCTTTTGCTTTATGAACCCCTGTTTTGTCATTAT GATTTTTCACTTGTTTTAACAGTTTCAGATGTCACCTTGGAATAGCACTGTTTATTTTGGCCTTTTTATGATTGCTGATGATAGGTACAG TCTAAAGGCCAAAAGTTGCCACTTCATTGTGATAACATTGTTGCAACATTCCTAATATATTAGAGAATGATGTAAAATAAGAATGTTAGA GAACATAGCACATTCTCATTCAGTTTATAAACAATATTTGAAAATTTCCAGTGAGAATTAAAAAAGGACTAGTGATGATATAGCAAACCT GGACCTGAAATTTGGGGGTGGGGGGTGGGGGGATATCTGTTTTGCAGAGAAAATTTACCAGCCTCCAGCAAAATCTCTGCATCTTGTACT CAATAGCAACCATTAGTATTGTCATTTAAAAAGAATGAATCAAAAATTCATACGTAATGGAATGAAAAGAGGAAAACTTTCTATTAAACA CTGTCAAGAAAGACCCATTGCTATCTATCACCTATGAAATTAAACCTAAAAAAATTTTTTTTTATTGTAAAAGCGACTGCTCGTTGATGT CTGGAAGTGATCCAGACTTTGTTTCACTGTGATCCAAAAAGTTAGACATTCCTTCCATTTCTCAAGATTTGGTAACAATTTTTTTTTAAG TCAGCATTTCATATAATACATAAAATTAAGACAAATTAACTTACTGATATGTGGCCAATATCAACCCTTCTCACCCAACCCAAACATGTT CTGGAGATAGAAGGACTTATCCTCAATTATATTCCAGTAAATTTATCTCCATAATCTGTTTTATCCCCTAATGTATGATATATCTCACCA AATTTTTCTAGAATTGAATAAAAGCAGTTTTTGCTTAACTTGAATTTCCTTCCACAAATACAACCTTCAGCTCTTCCCTCTCTGTTTCCC TTTTGCCCACATTGCAAATAGTCTTCATAATAGAACCCTCACTGCAACTTAAAAGGGTCCCATTTCTTAACTCAGCATTTCATATACCAA GAACACTTGCAAAGATTTCTTCATAATGTGATTTTTTAATTTTTCAGTTCCAGAAGCATTTCCTACAGTTCGAACGTTATTTTTTCTCTC AGATTTTCAACTTGAAGCTTTGATTTGCACTGAATTAACTTGGATAAAATTTTAGTTTCTCTCTTCAGCTAACAGATTTGGAAGCAAATT ACAGTATACTTGAATAATTCAGGTACTACCTGTTGACCTGGAATTTTAGTGATTCTGGGAAAGTTTTCCAGACAAAGACACCAATAGAGT GAAGGGTTTTTTCCCCAATTACTATTTTATTGTTTTTTAAAATGCCTTTTTAAAACTTGTGTGATGTGGCAAAATAGTCATATGTTCAAT TAATTTATATTTTATTCATTCCTTTTCAATTCTGGTTATTATGTAACCTCAAGTACTTTATCTGTTCTTTTAAAGTATTTTATAAAATGA >6734_6734_3_ARNT-CBLB_ARNT_chr1_150849019_ENST00000505755_CBLB_chr3_105439094_ENST00000264122_length(amino acids)=603AA_BP=22 LGGGVARRRWHLRPWRRLLPTPESDGQGCPFCRCEIKGTEPIIVDPFDPRDEGSRCCSIIDPFGMPMLDLDDDDDREESLMMNRLANVRK CTDRQNSPVTSPGSSPLAQRRKPQPDPLQIPHLSLPPVPPRLDLIQKGIVRSPCGSPTGSPKSSPCMVRKQDKPLPAPPPPLRDPPPPPP ERPPPIPPDNRLSRHIHHVESVPSRDPPMPLEAWCPRDVFGTNQLVGCRLLGEGSPKPGITASSNVNGRHSRVGSDPVLMRKHRRHDLPL EGAKVFSNGHLGSEEYDVPPRLSPPPPVTTLLPSIKCTGPLANSLSEKTRDPVEEDDDEYKIPSSHPVSLNSQPSHCHNVKPPVRSCDNG HCMLNGTHGPSSEKKSNIPDLSIYLKGDVFDSASDPVPLPPARPPTRDNPKHGSSLNRTPSDYDLLIPPLGEDAFDALPPSLPPPPPPAR HSLIEHSKPPGSSSRPSSGQDLFLLPSDPFVDLASGQVPLPPARRLPGENVKTNRTSQDYDQLPSCSDGSQAPARPPKPRPRRTAPEIHH -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ARNT-CBLB |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000264122 | 8 | 19 | 891_927 | 401.0 | 983.0 | SH3KBP1 | |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000403724 | 8 | 15 | 891_927 | 401.0 | 771.0 | SH3KBP1 | |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000264122 | 8 | 19 | 543_568 | 401.0 | 983.0 | VAV1 | |
Tgene | CBLB | chr1:150849019 | chr3:105439094 | ENST00000403724 | 8 | 15 | 543_568 | 401.0 | 771.0 | VAV1 |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ARNT-CBLB |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ARNT-CBLB |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ARNT | C0000786 | Spontaneous abortion | 1 | CTD_human |
Hgene | ARNT | C0000822 | Abortion, Tubal | 1 | CTD_human |
Hgene | ARNT | C0009402 | Colorectal Carcinoma | 1 | CTD_human |
Hgene | ARNT | C0009404 | Colorectal Neoplasms | 1 | CTD_human |
Hgene | ARNT | C0014175 | Endometriosis | 1 | CTD_human |
Hgene | ARNT | C0019193 | Hepatitis, Toxic | 1 | CTD_human |
Hgene | ARNT | C0023452 | Childhood Acute Lymphoblastic Leukemia | 1 | CTD_human |
Hgene | ARNT | C0023453 | L2 Acute Lymphoblastic Leukemia | 1 | CTD_human |
Hgene | ARNT | C0023890 | Liver Cirrhosis | 1 | CTD_human |
Hgene | ARNT | C0025202 | melanoma | 1 | CTD_human |
Hgene | ARNT | C0027659 | Neoplasms, Experimental | 1 | CTD_human |
Hgene | ARNT | C0239946 | Fibrosis, Liver | 1 | CTD_human |
Hgene | ARNT | C0269102 | Endometrioma | 1 | CTD_human |
Hgene | ARNT | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human |
Hgene | ARNT | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human |
Hgene | ARNT | C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1 | CTD_human |
Hgene | ARNT | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human |
Hgene | ARNT | C3830362 | Early Pregnancy Loss | 1 | CTD_human |
Hgene | ARNT | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Hgene | ARNT | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |
Hgene | ARNT | C4552766 | Miscarriage | 1 | CTD_human |
Tgene | C0014072 | Experimental Autoimmune Encephalomyelitis | 1 | CTD_human | |
Tgene | C0026769 | Multiple Sclerosis | 1 | CTD_human | |
Tgene | C0751324 | Multiple Sclerosis, Acute Fulminating | 1 | CTD_human |